ReviewCureus2025
Prevalence of Type 2 Diabetes Mellitus and Its Microvascular Complications in Sri Lanka: A Systematic Review and Meta-Analysis.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends in Mortality from Diabetes and Other Non-Communicable Diseases Among Sri Lankan Adults: A Retrospective Population-Based Study, 2004-2020/2021.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The burden of type II diabetes and microvascular complications is increasing around the globe, especially in low- and middle-income countries. We conducted a systematic review and a meta-analysis to estimate the prevalence of type II diabetes and its microvascular complications to determine the nature of diabetes and its complications in Sri Lanka. A systematic review and meta-analysis were conducted by searching PubMed, EMBASE, and CINAHL for studies published between 2014 and 2024 on the prevalence of type II diabetes mellitus and its microvascular complications in Sri Lanka. Titles, abstracts, and full texts were screened against predefined inclusion/exclusion criteria, and data were extracted from eligible studies. Pooled prevalence estimates were calculated using a random effects model, with 95% confidence intervals, and results were presented using forest plots. Analyses were performed using Stata version 18 (StataCorp LLC, College Station, Texas, USA). A total of 1400 articles underwent title, abstract or full text screening and only 11 (0.8%) articles were left for the analysis, which satisfied the inclusion/exclusion criteria; 15839 people with type II diabetes mellitus (mean sample size n=2263 (SD 2374), with a mean age of 48.6 years (SD 4.94)), were included. The estimated overall prevalence of type II diabetes, diabetic retinopathy and neuropathy was 17% (95% CI 17% to 18%), 13% (95% CI 13% to 14%) and 19% (95% CI 16% to 21%), respectively. The forest plots illustrated variation across individual studies but also showed a consistent upward trend in the prevalence of diabetes over time, with more recent studies reporting higher estimates. Further research into cost-effective methods for early identification and treatment of people with diabetes is needed to reduce the associated morbidity and mortality. Screening for complications at the time of diagnosis should become a routine practice to provide rapid intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.